BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Cordis Corporation (JNJ) And Brivant Limited Sign Distribution Agreement For Three Interventional Products


9/21/2006 12:12:30 PM

MIAMI, Sept. 21 /PRNewswire/ -- Cordis Corporation announced today that it has signed a definitive agreement whereby Cordis will be the worldwide distributor of Brivant's most advanced guidewires, which are products used to place catheters and drug-eluting stents in a patient's coronary system. The wires can also be used for products targeting the peripheral system.

"The addition of these three guidewires to our current line of innovative products adds depth to our cardiology and vascular portfolios," said Rick Anderson, Company Group Chairman, Johnson & Johnson and Worldwide Franchise Chairman, Cordis Corporation. "This agreement extends our commitment to physicians and the millions of people they treat with coronary and vascular diseases."

The three products covered under this agreement include a general-purpose guidewire, a guidewire targeted for highly stenosed lesions and a specialty J-tip guidewire used to navigate challenging anatomies. Cordis will market these guidewire products under an umbrella brand known as REGATTA(TM).

In recent months, Cordis has been strengthening its portfolio of catheters and balloons. Cordis recently announced availability in the United States, Canada and Europe of the STEER-IT(TM) Deflecting Tip Guidewire, designed to help physicians treat hard-to-reach blockages, and the launch an advanced percutaneous transluminal coronary angioplasty (PTCA) balloon catheter called the CRESCENDO(TM) PTCA Balloon Dilation Catheter in all countries except the U.S, Japan and Canada.

About Cordis Corporation

Cordis Corporation, a Johnson & Johnson company, is a worldwide leader in developing and manufacturing interventional vascular technology. Through the company's innovation, research and development, physicians worldwide are better able to treat the millions of patients who suffer from vascular disease.

Cordis Corporation

CONTACT: Christopher Allman, Cordis Cardiology, +1-786-313-2303, Mobile:+1-305-586-6024, Callman1@crdus.jnj.com


Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->